• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

16/09/2025 19:29

Dr Reddy’s launches Tegoprazan in India for Acid-Related Gastrointestinal Disorders

Dr Reddy’s Laboratories on Tuesday announced the launch of Tegoprazan (50 mg) under the brand name PCAB in India to treat acid-related gastrointestinal conditions.

Tegoprazan, a next-generation potassium-competitive acid blocker, is indicated for managing acid peptic diseases (APD) such as Erosive Gastroesophageal Reflux Disease (GERD), Non-Erosive GERD (NERD), and Gastric Ulcers.